AC Immune S.A. | Key People and Executives
Andrea Pfeifer
CEO, Director & Head-Investor Relations
Werner Lanthaler
Director
Douglas E. Williams
Director
Friedrich von Bohlen und Halbach
Independent Non-Executive Director
Thomas Graney
Independent Non-Executive Director
Andrea Pfeifer
CEO, Director & Head-Investor Relations
Jörg Hornstein
Chief Financial Officer
Andreas Muhs
Chief Scientific Officer
Jean-Fabien Monin
Chief Administrative Officer
Wolfgang Barth
Development Director
Werner Lanthaler
Director
Douglas E. Williams
Director
Beatrix Benz Grima
Head-Corporate Communications
Eva Schier
Manager-Communications & Media Contact
Matthias Staehelin
Secretary
Friedrich von Bohlen und Halbach
Independent Non-Executive Director
Thomas Graney
Independent Non-Executive Director
Peter Bollmann
Independent Non-Executive Director
Detlev H. Riesner
Independent Non-Executive Director
| Address |
EPFL Innovation Park
Lausanne Basel-Landschaft (Basle Country) 1015
Switzerland
|
|
Employees
|
- |
| Website |
http://www.acimmune.com |
| Updated |
07/08/2019 |
| AC Immune SA is a clinical stage biopharmaceutical company, which engages in developing therapeutic and diagnostic products. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company was founded by Jean-Marie Lehn, Claude Nicolau, Roscoe Brady, Fred van Leuven, Ruth Greferath, and Andrea Pfeifer on February 13, 2003 and is headquartered in Lausanne, Switzerland. |
